I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 5 studies | 30% ± 7% | |
| epithelial cell | 3 studies | 29% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 5 studies | 30% ± 7% | |
| epithelial cell | 3 studies | 29% ± 5% |
Insufficient scRNA-seq data for expression of SLC35A2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 702.37 | 180 / 180 | 100% | 52.35 | 430 / 430 |
| stomach | 100% | 1182.10 | 359 / 359 | 100% | 51.71 | 286 / 286 |
| uterus | 100% | 928.32 | 170 / 170 | 100% | 46.25 | 459 / 459 |
| esophagus | 100% | 1106.52 | 1444 / 1445 | 100% | 37.07 | 183 / 183 |
| lung | 100% | 1449.38 | 578 / 578 | 100% | 52.14 | 1153 / 1155 |
| skin | 100% | 1664.95 | 1809 / 1809 | 100% | 37.80 | 471 / 472 |
| breast | 100% | 1072.02 | 459 / 459 | 100% | 55.80 | 1114 / 1118 |
| pancreas | 100% | 1200.67 | 328 / 328 | 99% | 46.32 | 177 / 178 |
| intestine | 100% | 1213.25 | 966 / 966 | 99% | 57.01 | 524 / 527 |
| bladder | 100% | 951.05 | 21 / 21 | 99% | 54.02 | 500 / 504 |
| prostate | 100% | 1224.28 | 245 / 245 | 99% | 46.44 | 497 / 502 |
| brain | 99% | 709.00 | 2619 / 2642 | 100% | 21.48 | 703 / 705 |
| liver | 100% | 1291.00 | 226 / 226 | 99% | 27.99 | 400 / 406 |
| thymus | 100% | 1303.53 | 653 / 653 | 99% | 27.73 | 596 / 605 |
| kidney | 100% | 1364.00 | 89 / 89 | 98% | 26.07 | 879 / 901 |
| adrenal gland | 100% | 1607.62 | 258 / 258 | 94% | 23.39 | 217 / 230 |
| adipose | 100% | 988.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 26.33 | 29 / 29 |
| spleen | 100% | 1151.77 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 36.78 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 37.91 | 1 / 1 |
| blood vessel | 100% | 884.08 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 20.96 | 79 / 80 |
| heart | 99% | 673.26 | 849 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 510.58 | 787 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 789.91 | 896 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0072334 | Biological process | UDP-galactose transmembrane transport |
| GO_0006012 | Biological process | galactose metabolic process |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005459 | Molecular function | UDP-galactose transmembrane transporter activity |
| GO_0015297 | Molecular function | antiporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC35A2 |
| Protein name | UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT) SLC35A2 protein Solute carrier family 35 member A2 (cDNA FLJ53300, highly similar to UDP-galactose translocator) Solute carrier family 35 member A2 (cDNA FLJ59970, highly similar to UDP-galactose translocator) Solute carrier family 35 member A2 |
| Synonyms | UGT UGALT UGTL |
| Description | FUNCTION: Transports uridine diphosphate galactose (UDP-galactose) from the cytosol into the Golgi apparatus, functioning as an antiporter that exchanges UDP-galactose for UMP . It is also able to exchange UDP-galactose for AMP and CMP, and to transport UDP-N-acetylgalactosamine (UDP-GalNAc) and other nucleotide sugars . As a provider of UDP-galactose to galactosyltransferases present in the Golgi apparatus, it is necessary for globotriaosylceramide/globoside (Gb3Cer) synthesis from lactosylceramide . . |
| Accessions | ENST00000446885.1 ENST00000635015.1 A0A0U1RR61 A0A0U1RR48 ENST00000376515.8 P78381 B4DE15 Q6ICV6 B4DSH7 C9JCV5 ENST00000635238.1 ENST00000710056.1 [P78381-2] A6NGW4 A0A0U1RRB4 ENST00000710060.1 [P78381-5] ENST00000635589.1 [P78381-5] ENST00000616181.5 ENST00000710052.1 [P78381-1] ENST00000376512.2 ENST00000634461.1 A0A0U1RRG4 ENST00000452555.7 [P78381-4] ENST00000710062.1 [P78381-4] ENST00000247138.11 [P78381-1] ENST00000376529.8 A0A0U1RRN1 ENST00000710057.1 [P78381-3] ENST00000635285.1 [P78381-2] A6NKM8 A0A0X1KG77 ENST00000635628.1 ENST00000376521.6 [P78381-2] ENST00000635460.1 A6NFI1 ENST00000413561.7 ENST00000634665.1 ENST00000445167.7 [P78381-3] ENST00000710051.1 [P78381-2] |
